Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davidson

Showing results (1-10 of 358) with videos related to

Pageof 36
Sort By:
Expert Review of Molecular Diagnostics|May 11, 2019
Biomarkers of drug resistance in ovarian cancer - an updateBen Davidson
Biomarker Insights|August 8, 2009
Expression of cancer-associated molecules in malignant mesotheliomaBen Davidson
Acta Cytologica|August 18, 2016
Malignant Nonhematological Effusion Characterization by Flow CytometryBen Davidson
Diagnostic Cytopathology|September 29, 2004
Malignant effusions: from diagnosis to biologyBen Davidson
Current Cancer Drug Targets|February 20, 2007
Anatomic site-related expression of cancer-associated molecules in ovarian carcinomaBen Davidson
Acta Cytologica|April 10, 2026
Recently identified diagnostic markers in effusion cytologyBen Davidson
Ultrastructural Pathology|January 2, 2009
New diagnostic and molecular characteristics of malignant mesotheliomaBen Davidson
Human Pathology|April 1, 2015
Prognostic factors in malignant pleural mesotheliomaBen Davidson
Diagnostic Cytopathology|February 6, 2020
Molecular testing on serous effusionsBen Davidson
Critical Reviews in Oncogenesis|February 27, 2008
Biological characteristics of cancers involving the serosal cavitiesBen Davidson
Pageof 36

Showing results (1-10 of 358) with videos related to

Sort By:
Pageof 36
Expert Review of Molecular Diagnostics|May 11, 2019
Biomarkers of drug resistance in ovarian cancer - an updateBen Davidson
Biomarker Insights|August 8, 2009
Expression of cancer-associated molecules in malignant mesotheliomaBen Davidson
Acta Cytologica|August 18, 2016
Malignant Nonhematological Effusion Characterization by Flow CytometryBen Davidson
Diagnostic Cytopathology|September 29, 2004
Malignant effusions: from diagnosis to biologyBen Davidson
Current Cancer Drug Targets|February 20, 2007
Anatomic site-related expression of cancer-associated molecules in ovarian carcinomaBen Davidson
Acta Cytologica|April 10, 2026
Recently identified diagnostic markers in effusion cytologyBen Davidson
Ultrastructural Pathology|January 2, 2009
New diagnostic and molecular characteristics of malignant mesotheliomaBen Davidson
Human Pathology|April 1, 2015
Prognostic factors in malignant pleural mesotheliomaBen Davidson
Diagnostic Cytopathology|February 6, 2020
Molecular testing on serous effusionsBen Davidson
Critical Reviews in Oncogenesis|February 27, 2008
Biological characteristics of cancers involving the serosal cavitiesBen Davidson
Pageof 36